DE69633133D1 - TFPI-verwandte Peptide die das Wachstums von glatten Muskelzellen inhibieren - Google Patents
TFPI-verwandte Peptide die das Wachstums von glatten Muskelzellen inhibierenInfo
- Publication number
- DE69633133D1 DE69633133D1 DE69633133T DE69633133T DE69633133D1 DE 69633133 D1 DE69633133 D1 DE 69633133D1 DE 69633133 T DE69633133 T DE 69633133T DE 69633133 T DE69633133 T DE 69633133T DE 69633133 D1 DE69633133 D1 DE 69633133D1
- Authority
- DE
- Germany
- Prior art keywords
- peptide
- smooth muscle
- amino acid
- muscle cells
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 210000000329 smooth muscle myocyte Anatomy 0.000 title abstract 3
- 102100030951 Tissue factor pathway inhibitor Human genes 0.000 title 1
- 108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 125000000539 amino acid group Chemical group 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000031481 Pathologic Constriction Diseases 0.000 abstract 1
- 206010039491 Sarcoma Diseases 0.000 abstract 1
- 238000002399 angioplasty Methods 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 210000002460 smooth muscle Anatomy 0.000 abstract 1
- 208000037804 stenosis Diseases 0.000 abstract 1
- 230000036262 stenosis Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30079295 | 1995-10-24 | ||
JP30079295 | 1995-10-24 | ||
PCT/JP1996/003080 WO1997015598A1 (en) | 1995-10-24 | 1996-10-23 | Novel peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69633133D1 true DE69633133D1 (de) | 2004-09-16 |
DE69633133T2 DE69633133T2 (de) | 2005-07-28 |
Family
ID=17889159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69633133T Expired - Fee Related DE69633133T2 (de) | 1995-10-24 | 1996-10-23 | TFPI-verwandte Peptide die das Wachstums von glatten Muskelzellen inhibieren |
Country Status (9)
Country | Link |
---|---|
US (1) | US6191113B1 (de) |
EP (1) | EP0867450B1 (de) |
JP (1) | JP3930050B2 (de) |
KR (1) | KR100465222B1 (de) |
AT (1) | ATE273322T1 (de) |
AU (1) | AU719366B2 (de) |
CA (1) | CA2232240C (de) |
DE (1) | DE69633133T2 (de) |
WO (1) | WO1997015598A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0933423B1 (de) * | 1996-02-23 | 2007-08-22 | Mochida Pharmaceutical Co., Ltd. | Meltrine |
US5981471A (en) * | 1997-02-06 | 1999-11-09 | Entremed, Inc. | Compositions and methods for inhibiting cellular proliferation |
TWI257307B (en) * | 2000-07-12 | 2006-07-01 | Orthologic Corp | Pharmaceutical composition for cardiac tissue repair |
KR100889993B1 (ko) | 2001-07-13 | 2009-03-25 | 씨엠에스 펩티드 패턴트 홀딩 컴퍼니 리미티드 | 생물학적 활성 펩타이드 |
CA2472381C (en) * | 2002-01-09 | 2014-04-29 | Suntory Limited | Glycosyltransferase gnt-v having neovascularization action |
WO2004014937A2 (en) * | 2002-07-02 | 2004-02-19 | The Board Of Regents, The University Of Texas System | Thrombin peptide derivatives |
TWI353252B (en) | 2004-04-28 | 2011-12-01 | Cms Peptides Patent Holding Company Ltd | Biologically active peptide vapeehptllteaplnpk der |
CA2616525C (en) | 2005-07-26 | 2014-06-17 | Cms Peptides Patent Holding Company Limited | Novel biologically active peptides and their new uses |
EP2063910A2 (de) * | 2006-09-22 | 2009-06-03 | Orthologic Corp. | Verfahren zur behandlung von endothelialer dysfunktion |
EP2268304A2 (de) * | 2008-03-26 | 2011-01-05 | Orthologic Corp. | Verfahren zur behandlung akuter myokardinfarkte |
US9228022B2 (en) | 2010-06-30 | 2016-01-05 | Novo Nordisk A/S | Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
EP2588499B1 (de) * | 2010-06-30 | 2020-04-08 | Novo Nordisk A/S | Zur bindung des gewebefaktor-gerinnungsweg-inhibitors fähige antikörper |
PL236566B1 (pl) | 2012-12-17 | 2021-01-25 | Univ Jagiellonski | Peptyd chemerynowy, kompozycja farmaceutyczna zawierająca taki peptyd, oraz jego zastosowanie |
JPWO2019176860A1 (ja) * | 2018-03-15 | 2021-01-14 | 東レ株式会社 | 細胞接着性材料 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849536A (en) * | 1990-03-02 | 1998-12-15 | Bio-Technology General Corp. | Cloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using same |
US5254536A (en) * | 1992-01-10 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | Therapeutic utility of plasminogen activator inhibitor-1 to control bleeding |
AU5715194A (en) | 1992-12-04 | 1994-07-04 | N.V. Innogenetics S.A. | New polypeptides, nucleic acid sequences encoding them, and their use to prevent the adhesion of f107-fimbriated bacteria |
JP3428687B2 (ja) | 1993-06-30 | 2003-07-22 | 財団法人化学及血清療法研究所 | 組織因子凝固系インヒビターの調製法 |
US5824644A (en) * | 1994-07-07 | 1998-10-20 | G. D. Searle & Co. | Method of attenuating arterial stenosis |
US5589359A (en) * | 1994-08-05 | 1996-12-31 | Chiron Corporation | Chimeric proteins |
JPH0859698A (ja) * | 1994-08-15 | 1996-03-05 | Teijin Ltd | 血液凝固調節能を有する新規ペプチド |
US5639726A (en) * | 1994-09-30 | 1997-06-17 | The Regents Of The University Of Michigan | Peptide mediated enhancement of thrombolysis methods and compositions |
JPH09124506A (ja) | 1995-08-29 | 1997-05-13 | Chemo Sero Therapeut Res Inst | 組織因子凝固系インヒビター含有動脈硬化治療剤 |
US5772629A (en) * | 1995-10-23 | 1998-06-30 | Localmed, Inc. | Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels |
US5981471A (en) * | 1997-02-06 | 1999-11-09 | Entremed, Inc. | Compositions and methods for inhibiting cellular proliferation |
-
1996
- 1996-10-23 US US09/051,986 patent/US6191113B1/en not_active Expired - Fee Related
- 1996-10-23 KR KR10-1998-0702898A patent/KR100465222B1/ko not_active IP Right Cessation
- 1996-10-23 EP EP96935411A patent/EP0867450B1/de not_active Expired - Lifetime
- 1996-10-23 AT AT96935411T patent/ATE273322T1/de not_active IP Right Cessation
- 1996-10-23 JP JP51647497A patent/JP3930050B2/ja not_active Expired - Fee Related
- 1996-10-23 AU AU73357/96A patent/AU719366B2/en not_active Ceased
- 1996-10-23 CA CA002232240A patent/CA2232240C/en not_active Expired - Fee Related
- 1996-10-23 DE DE69633133T patent/DE69633133T2/de not_active Expired - Fee Related
- 1996-10-23 WO PCT/JP1996/003080 patent/WO1997015598A1/ja active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE69633133T2 (de) | 2005-07-28 |
US6191113B1 (en) | 2001-02-20 |
CA2232240A1 (en) | 1997-05-01 |
WO1997015598A1 (en) | 1997-05-01 |
CA2232240C (en) | 2007-01-16 |
ATE273322T1 (de) | 2004-08-15 |
EP0867450A1 (de) | 1998-09-30 |
KR19990066965A (ko) | 1999-08-16 |
AU7335796A (en) | 1997-05-15 |
JP3930050B2 (ja) | 2007-06-13 |
AU719366B2 (en) | 2000-05-04 |
EP0867450A4 (de) | 2000-01-19 |
KR100465222B1 (ko) | 2005-05-17 |
EP0867450B1 (de) | 2004-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE273322T1 (de) | Tfpi-verwandte peptide die das wachstums von glatten muskelzellen inhibieren | |
DE69028535D1 (de) | Herstellung des vaskulären endothelialen zellwachstumsfaktors | |
DE69627704D1 (en) | Protegrine | |
CA2153789A1 (en) | Biologically active tgf-.beta.1 and tgf-.beta.2 peptides | |
DE68916932T2 (de) | Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus. | |
ATE209215T1 (de) | Protegrine | |
DE69130696T2 (de) | Ein neues, biologisch aktives vom Huhn stammendes Peptid (Huhn-CNP) | |
IS2819B (is) | Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra | |
ES2081817T3 (es) | Polipeptido con secuencias principales repetidas que se fijan en la celula. | |
DE69126049T2 (de) | Vektoren und Zusammensetzungen zur Expression von Glykosilationsmutanten des menschlichen Proteins-C | |
HU895788D0 (en) | Process for producing peptides and medical products containing them | |
DE68921229T2 (de) | Prozess zur Behandlung von unlöslichem heterogenem Fusionsprotein. | |
HUT53125A (en) | Process for producing peptides with anticoagulant activity | |
ATE143974T1 (de) | Peptide des hiv-gag proteins, ihre herstellung und verwendung | |
DE69126563T2 (de) | Verwendung einer Mischung von Peptiden and Aminosäuren für die Prophylaxis oder Behandlung von Dementia | |
EP0241136A3 (de) | Humaner, Klasse 1 Heparin bindender, Wachstumsfaktor | |
ATE145939T1 (de) | Mitogen für die glatte muskulatur und dessen kodierende dns | |
KR950701347A (ko) | 신규한 향종양성 사이토킨(A novel anti-neoplastic cytokine) | |
DK0423326T3 (da) | Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta | |
EP0446361A4 (en) | Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide | |
DE3876788T2 (de) | Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff. | |
RU93041779A (ru) | Средство для лечения иммунодефицитных состояний | |
RU93056862A (ru) | Способ предотвращения рестеноза или снижения его степени |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |